DrugPatentWatch Database Preview
Drugs in Development Information for Masitinib
Drug Development Status for Masitinib: Sponsors, patents, clinical trial progress
Masitinib is an investigational drug.
There have been 30 clinical trials for Masitinib.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2008.
The most common disease conditions in clinical trials are Gastrointestinal Stromal Tumors, Sclerosis, and Recurrence. The leading clinical trial sponsors are AB Science and [disabled in preview].
Summary for Masitinib
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 79 |
| WIPO Patent Applications | 67 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2008-11-01) |
| Vendors | 75 |
Recent Clinical Trials for Masitinib
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients | AB Science | Phase 3 |
| Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels | AB Science | Phase 3 |
| Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer | AB Science | Phase 2/Phase 3 |
Clinical Trial Summary for Masitinib
Top disease conditions for Masitinib
Top clinical trial sponsors for Masitinib
US Patents for Masitinib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
